- Report
- March 2019
- 62 Pages
Global
€9650EUR$10,000USD£8,151GBP
- Report
- March 2019
- 33 Pages
Global
€9650EUR$10,000USD£8,151GBP
- Report
- April 2018
- 38 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- April 2018
- 34 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- April 2018
- 38 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- April 2018
- 26 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- April 2018
- 25 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- April 2018
- 31 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- March 2018
- 16 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- March 2018
- 16 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- March 2018
- 20 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- March 2018
- 17 Pages
Global
From €9650EUR$10,000USD£8,151GBP
- Report
- May 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,038GBP
- Report
- June 2023
- 157 Pages
Global
From €2413EUR$2,500USD£2,038GBP
- Report
- January 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,038GBP
- Report
- May 2019
- 84 Pages
Global
From €6750EUR$6,995USD£5,702GBP
- Drug Pipelines
- September 2022
- 129 Pages
Global
From €10611EUR$10,995USD£8,962GBP
- Drug Pipelines
- February 2022
- 60 Pages
Global
From €6750EUR$6,995USD£5,702GBP
- Report
- June 2021
- 55 Pages
Global
From €6750EUR$6,995USD£5,702GBP
- Report
- April 2018
Global
From €965EUR$1,000USD£815GBP
The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more